Cargando…

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?

OBJECTIVE: The replacement of cytology with human papillomavirus testing as the primary cervical screening test in England is imminent. In light of newly available evidence, we revised our previous estimates of the likely impact of primary human papillomavirus testing on incidence of cervical cancer...

Descripción completa

Detalles Bibliográficos
Autores principales:	Castanon, Alejandra, Landy, Rebecca, Sasieni, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2016
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490776/ https://www.ncbi.nlm.nih.gov/pubmed/27363972 http://dx.doi.org/10.1177/0969141316654197

Ejemplares similares

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study
por: Castanon, Alejandra, et al.
Publicado: (2017)

How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study
por: Wuntakal, R., et al.
Publicado: (2015)

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study
por: Landy, Rebecca, et al.
Publicado: (2016)

Cervical Screening at Age 50–64 Years and the Risk of Cervical Cancer at Age 65 Years and Older: Population-Based Case Control Study
por: Castañón, Alejandra, et al.
Publicado: (2014)

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
por: Castañon, Alejandra, et al.
Publicado: (2018)

Survival from Cervical Cancer Diagnosed Aged 20–29 Years by Age at First Invitation to Screening in England: Population-Based Study
por: Castanon, Alejandra, et al.
Publicado: (2020)

Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study
por: Castanon, Alejandra, et al.
Publicado: (2014)

Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern?
por: Castanon, Alejandra, et al.
Publicado: (2018)

Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years
por: Landy, R, et al.
Publicado: (2014)

Response to comment on ‘Characteristics and screening history of women diagnosed with cervical cancer aged 20–29'
por: Castanon, A, et al.
Publicado: (2014)

Impact of screening on cervical cancer incidence in England: a time trend analysis
por: Pesola, Francesca, et al.
Publicado: (2019)

Cervical cytology and the diagnosis of cervical cancer in older women
por: Landy, Rebecca, et al.
Publicado: (2015)

Predicted impact of vaccination against human papillomavirus 16/18 on cancer incidence and cervical abnormalities in women aged 20–29 in the UK
por: Cuzick, J, et al.
Publicado: (2010)

Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review
por: Lim, Anita WW, et al.
Publicado: (2016)

Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study
por: Castanon, Alejandra, et al.
Publicado: (2020)

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
por: Sasieni, Peter, et al.
Publicado: (2009)

Systematic Review and Meta-Analysis of Individual Patient Data to Assess the Sensitivity of Cervical Cytology for Diagnosis of Cervical Cancer in Low- and Middle-Income Countries
por: Castanon, Alejandra, et al.
Publicado: (2017)

audit_cc: A Stata command for the analysis of matched case-control audits of cervical cancer screening
por: Falcaro, Milena, et al.
Publicado: (2023)

Characteristics and screening history of women diagnosed with cervical cancer aged 20–29 years
por: Castanon, A, et al.
Publicado: (2013)

COVID-19 disruption to cervical cancer screening in England
por: Castanon, Alejandra, et al.
Publicado: (2022)

Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses
por: Castanon, Alejandra, et al.
Publicado: (2021)

Impact of screening between the ages of 60 and 64 on cumulative rates of cervical cancer to age 84y by screening history at ages 50 to 59: A population-based case-control study
por: Castanon, Alejandra, et al.
Publicado: (2021)

Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study
por: Castanon, Alejandra, et al.
Publicado: (2022)

Are women ready for the new cervical screening protocol in England? A systematic review and qualitative synthesis of views about human papillomavirus testing
por: Hendry, M, et al.
Publicado: (2012)

What cervical screening is appropriate for women who have been vaccinated against high risk HPV? A simulation study
por: Landy, Rebecca, et al.
Publicado: (2017)

Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study
por: Castanon, Alejandra, et al.
Publicado: (2012)

Exposure Definition in Case–Control Studies of Cervical Cancer Screening: A Systematic Literature Review
por: Castanon, Alejandra, et al.
Publicado: (2021)

Evaluating cytology for the detection of invasive cervical cancer
por: Landy, R., et al.
Publicado: (2015)

Impact of screening on cervical cancer incidence: A population‐based case–control study in the United States
por: Landy, Rebecca, et al.
Publicado: (2019)

Longitudinal Clinical Performance of the RNA-Based Aptima Human Papillomavirus (AHPV) Assay in Comparison to the DNA-Based Hybrid Capture 2 HPV Test in Two Consecutive Screening Rounds with a 6-Year Interval in Germany
por: Iftner, Thomas, et al.
Publicado: (2019)

Prevalence of human papillomavirus antibodies in young female subjects in England
por: Jit, M, et al.
Publicado: (2007)

Cervical Cancer Screening after Perimenopause: How Is Human Papillomavirus Test Performed?
por: Chung, Soo-Ho
Publicado: (2016)

Non-speculum sampling approaches for cervical screening in older women: randomised controlled trial
por: Landy, Rebecca, et al.
Publicado: (2021)

Is the increased risk of preterm birth following excision for cervical intraepithelial neoplasia restricted to the first birth post treatment?
por: Castañon, A, et al.
Publicado: (2015)

Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023)

Self-sampling for cervical screening offered at the point of invitation: A cross-sectional study of preferences in England
por: Drysdale, Hannah, et al.
Publicado: (2022)

Non-speculum clinician-taken samples for human papillomavirus testing: a cross-sectional study in older women
por: Landy, Rebecca, et al.
Publicado: (2022)

Reducing Ozone How Much Is It Worth?
por: Hood, E
Publicado: (2001)

Human papillomavirus testing in cervical cancer screening
por: Franceschi, S, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_8mqjr159tfo4tj35467mpct30e